These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 19871615)
1. ACTIVE IMMUNITY TO POLIOMYELITIS IN CHIMPANZEES FOLLOWING SUBCLINICAL INFECTION. Melnick JL; Horstmann DM J Exp Med; 1947 Feb; 85(3):287-303. PubMed ID: 19871615 [TBL] [Abstract][Full Text] [Related]
2. Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. I. The virus carrier state and the development of neutralizing antibodies. MELNICK JL; KAPLAN AS J Exp Med; 1953 Mar; 97(3):367-400. PubMed ID: 13052807 [TBL] [Abstract][Full Text] [Related]
3. Poliomyelitis in chimpanzees; studies in homologous and heterologous immunity following inapparent infection. HORSTMANN DM; MELNICK JL J Exp Med; 1950 Jun; 91(6):573-97. PubMed ID: 15422085 [TBL] [Abstract][Full Text] [Related]
4. Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. II. The development of complement-fixing antibodies. KRAFT LM; MELNICK JL J Exp Med; 1953 Mar; 97(3):401-14. PubMed ID: 13052808 [TBL] [Abstract][Full Text] [Related]
5. Oral administration of a rodent-adapted strain of poliomyelitis virus to chimpanzees. KOPROWSKI H; JERVIS GA; NORTON TW Arch Gesamte Virusforsch; 1954; 5(5):413-24. PubMed ID: 13218593 [No Abstract] [Full Text] [Related]
6. A specific complement-fixation test for infection with poliomyelitis virus. CASALS J; OLITSKY PK; ANSLOW RO J Exp Med; 1951 Aug; 94(2):123-37. PubMed ID: 14861374 [TBL] [Abstract][Full Text] [Related]
7. Relationship between serum antibodies and subclinical infections with poliomyelitis virus. BROWN GC; AINSLIE JD J Exp Med; 1951 Mar; 93(3):197-205. PubMed ID: 14824395 [TBL] [Abstract][Full Text] [Related]
8. Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzees. Gibbs CJ; Peters R; Gravell M; Johnson BK; Jensen FC; Carlo DJ; Salk J Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3348-52. PubMed ID: 2014254 [TBL] [Abstract][Full Text] [Related]
9. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458 [TBL] [Abstract][Full Text] [Related]
10. Studies on infection and immunity in experimental typhoid fever. I. Typhoid fever in chimpanzees orally infected with Salmonella typhosa. EDSALL G; GAINES S; LANDY M; TIGERTT WD; SPRINZ H; TRAPANI RJ; MANDEL AD; BENENSON AS J Exp Med; 1960 Jul; 112(1):143-66. PubMed ID: 13725751 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda. Mugisha L; Pauli G; Opuda-Asibo J; Joseph OO; Leendertz FH; Diedrich S J Med Primatol; 2010 Apr; 39(2):123-8. PubMed ID: 20102460 [TBL] [Abstract][Full Text] [Related]
12. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. Nara PL; Robey WG; Arthur LO; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC; Fischinger PJ J Virol; 1987 Oct; 61(10):3173-80. PubMed ID: 2442411 [TBL] [Abstract][Full Text] [Related]
13. Lack of protective immunity against reinfection with hepatitis C virus. Farci P; Alter HJ; Govindarajan S; Wong DC; Engle R; Lesniewski RR; Mushahwar IK; Desai SM; Miller RH; Ogata N Science; 1992 Oct; 258(5079):135-40. PubMed ID: 1279801 [TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Goudsmit J; Debouck C; Meloen RH; Smit L; Bakker M; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4478-82. PubMed ID: 2454471 [TBL] [Abstract][Full Text] [Related]
15. Immunization of chimpanzees and human beings with avirulent strains of poliomyelitis virus. SABIN AB Ann N Y Acad Sci; 1955 Sep; 61(4):1050-6. PubMed ID: 13340614 [No Abstract] [Full Text] [Related]
16. Effects of cyclophosphamide on hepatitis B virus infection and challenge in chimpanzees. Markenson JA; Gerety RJ; Hoofnagle JH; Barker LF J Infect Dis; 1975 Feb; 131(2):79-87. PubMed ID: 1117192 [TBL] [Abstract][Full Text] [Related]
17. Antibody response of chimpanzees and human beings to formalin-inactivated trivalent poliomyelitis vaccine. HOWE HA Am J Hyg; 1952 Nov; 56(3):265-86. PubMed ID: 12996495 [No Abstract] [Full Text] [Related]
18. THE SIGNIFICANCE OF LESIONS IN PERIPHERAL GANGLIA IN CHIMPANZEE AND IN HUMAN POLIOMYELITIS. Bodian D; Howe HA J Exp Med; 1947 Feb; 85(3):231-42. PubMed ID: 19871611 [TBL] [Abstract][Full Text] [Related]
19. Poliomyelitis virus in blood of orally infected monkeys and chimpanzees. HORSTMANN DM Proc Soc Exp Biol Med; 1952 Mar; 79(3):417-9. PubMed ID: 14920447 [No Abstract] [Full Text] [Related]
20. The recovery of poliomyelitis virus from the stools of monkeys and chimpanzees experimentally infected by various routes. MELNICK JL Fed Proc; 1946; 5(1 Pt 2):250. PubMed ID: 21064605 [No Abstract] [Full Text] [Related] [Next] [New Search]